Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Idaho guideIdaho Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Idaho
  4. ›Closed bids
  5. ›Cancer Registry

Idaho Department of Health and Welfare·Idaho

Cancer Registry

Closes 10/17/2025$500k – $2MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Idaho Department of Health and Welfare is seeking a qualified contractor to operate and maintain the statewide cancer registry, ensuring timely and accurate cancer data reporting in accordance with state and federal requirements. The selected contractor will be responsible for securing additional resources, such as federal grants or institutional support, to fully sustain registry operations. The contractor will need to provide a proposal that includes information about their ability to provide the services, as well as a cost proposal. • The contractor will be responsible for operating and maintaining the existing registry functions. • The contractor will need to secure additional resources to fully sustain registry operations. • The contractor will need to provide a proposal that includes information about their ability to provide the services. • The contractor will need to provide a cost proposal. • The contractor will need to comply with state and federal requirements for cancer data reporting.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Key dates

Opened
9/3/2025
Questions due
9/17/2025
Closes
10/17/2025

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
621111
Solicitation №
1022

Budget estimate

$500,000 – $2,000,000

The budget for this opportunity is likely to be in the range of $500,000 to $2 million per year, considering the scope of work involved in operating and maintaining a statewide cancer registry. The actual budget will depend on the contractor's proposed costs and the department's available funding. Factors that may influence the likely payment range include the complexity of the registry operations, the number of staff required, and the level of technical expertise needed.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Centers for Disease Control - NCCDPHP·United States of America

Top match · 71%

Promoting Cancer Surveillance Workforce, Education, and Data Use

Closes 4/6/2027Opened 9/28/2026

U.S. National Institutes of Health·United States of America

68% match

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 10/19/2026Opened 7/2/2025

Massachusetts Department of Public Health·Massachusetts

68% match

RFR 257030 Certified Oncology Data Specialist

Closes 6/30/2030Opened 3/6/2025

U.S. National Institutes of Health·United States of America

67% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 1/24/2027Opened 3/10/2026

U.S. National Institutes of Health·United States of America

67% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

67% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

66% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

66% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 2/5/2027Opened 9/3/2026

U.S. National Institutes of Health·United States of America

66% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 9/25/2028Opened 11/26/2025

U.S. National Institutes of Health·United States of America

66% match

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Closes 1/25/2027Opened 8/28/2025

U.S. National Institutes of Health·United States of America

65% match

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/24/2026

U.S. National Institutes of Health·United States of America

65% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

65% match

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Closes 10/19/2027Opened 7/2/2025

Mississippi Department of Health·Mississippi

65% match

Mississippi Partnership for Comprehensive Cancer Control Coalition

Closes 10/20/2026Opened 8/17/2026

U.S. National Institutes of Health·United States of America

65% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

U.S. Food and Drug Administration·United States of America

65% match

Novel approaches to support therapeutic development in ultra-rare cancers

Rolling / TBD closeOpened 8/4/2025

U.S. National Institutes of Health·United States of America

64% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024

U.S. National Institutes of Health·United States of America

64% match

Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Closes 1/24/2027Opened 6/2/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

64% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 3/6/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

64% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

64% match

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 10/19/2026Opened 7/2/2025

U.S. National Institutes of Health·United States of America

64% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

64% match

DoW Rare Cancers Resource and Community Development Award

Closes 11/18/2026Opened 6/17/2026

U.S. National Institutes of Health·United States of America

64% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

64% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025